ETF Daily News15 小时
Skye Bioscience, Inc. (NASDAQ:SKYE) Given Average Rating of “Buy” by Brokerages
The company's lead product candidate is SBI-100 used in the treatment of glaucoma and ocular hypertension. It is also ...